News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rexahn Pharmaceuticals, Inc. Closes Public Offering for $6,600,000 in Gross Proceeds


12/5/2012 10:50:08 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--REXAHN PHARMACEUTICALS, INC. (NYSE MKT: RNN) announced today the closing of its previously announced underwritten public offering of 19,130,435 units and a partial exercise of the over-allotment option by the underwriter for an additional 869,565 units, bringing the total units offered to 20,000,000. The offering was priced at $0.33 per unit. Each unit consists of one share of common stock and a warrant to purchase up to 0.55 of a share of common stock. The warrants have an exercise price of $0.472 per whole share of common stock.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES